PFE
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% change compared to its last...
Read moreDetails
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why...
Read moreDetails
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock...
Read moreDetails
Is Pfizer Stock Undervalued at Current Prices?
Pfizer (PFE -0.07%) stock investors are curious about the valuation and prospects for the healthcare company.
Read moreDetails
Should You Buy Pfizer Stock Right Now in 2025?
Pfizer (PFE 0.20%) is an interesting healthcare company with excellent prospects for cash flow growth.
Read moreDetails
Pfizer Rises 5.6% in a Month: How Should You Play the Stock?
Pfizer's PFE stock has risen 5.6% in the past month. This was due to the company's encouraging guidance for 2025...
Read moreDetails
The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP
Berkshire Hathaway, The Home Depot, Pfizer and AMREP are included in this Analyst Blog.
Read moreDetails
Pfizer (PFE) Advances While Market Declines: Some Information for Investors
In the latest trading session, Pfizer (PFE) closed at $26.61, marking a +0.3% move from the previous day.
Read moreDetails
Here’s Why Pfizer (PFE) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why...
Read moreDetails
Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics
Collaboration will leverage Atavistik Bio's proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated...
Read moreDetails